Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4.
Gockel
Ines
I
Schimanski
Carl C
CC
Moehler
Markus
M
Junginger
Theodor
T
D000970:Antineoplastic Agents / Q000494:pharmacology*; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D016503:Drug Delivery Systems / Q000639:trends; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D020360:Neoadjuvant Therapy; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D019718:Receptors, CXCR4; D018844:Cyclin-Dependent Kinases